INTERFERENCES DUE TO HYPERTRIGLYCERIDEMIA IN ROUTINE CLINICAL BIOCHEMICAL TESTS
Main Article Content
Abstract
Lipemic specimens are common in clinical chemistry and may produce significant interferences in the analytical results of different routine clinical biochemical tests. Objectives: Evaluate the influence of different triglyceride concentrations in human plasma on 12 parameters. Methods: The leftover plasma samples obtained daily in the laboratory were spiked with the different concentrations of Lipovenoes® 10% PLR, being determined a variety of biochemical tests before and after treatment. Results and conclusions: Lipemia interferes the clinical biochemical parameters. The interference increases with hypertriglycidemia levels but does not exceed the total acceptable errors for amylase, lipase, glucose, urea, creatinine, albumin, protein and potassium assays at all analyte concentrations, except for glucose at very low concentrations (< 2.2 mmol/L). The interference bias is greater than the total acceptable errors for ALT and AST testing at moderate lipemic concentration, and for sodium and chloride at severe lipemic concentration.
Article Details
Keywords
lipemic samples, hypertri-glyceridemia, clinical biochemical tests
References

2. C. J. Farrell and A. C. Carter, "Serum indices: managing assay interference," Ann Clin Biochem, vol. 53, no. Pt 5, pp. 527-38, 2016.

3. M. R. Glick, K. W. Ryder and S. A. Jackson, "Graphical comparisons of interferences in clinical chemistry instrumentation," Clin Chem USA, vol. 32, no. 3, pp. 470-5, 1986.

4. O. Sonntag and A. Scholer, "Drug interference in clinical chemistry: recommendation of drugs and their concentrations to be used in drug interference studies," Ann Clin Biochem, vol. 38, no. Pt 4, pp. 376-85, 2001.

5. Saracevic, N. Nikolac and A. M. Simundic, "The evaluation and comparison of consecutive high speed centrifugation and LipoClear(R) reagent for lipemia removal," Clin Biochem, vol. 47, no. 4-5, pp. 309-14, 2014.

6. M. Grunbaum, B. M. Gilfix and R. S. Hoffman, "Review of the effect of intravenous lipid emulsion on laboratory analyses," Clin Toxicol (Phila), vol. 54, no. 2, pp. 92-102, 2016.

7. Westgard, "westgard.com," Westgard QC, 2014. [Online]. Available: https://westgard.com/ clia-a-quality/quality-requirements/biodatabase1. html. [Accessed 01 12 2024].

8. N. Nikolac, A. M. Simundic and M. Miksa, "Heterogeneity of manufacturers' declarations for lipemia interference - an urgent call for standardization," Clin Chim Acta, vol. 426, pp. 33-40, 2013.
